Status:
RECRUITING
Collection of Biological Samples from Patients with Rare Neurological Diseases
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Nervous System Diseases
Eligibility:
All Genders
6-99 years
Brief Summary
The aim of this project is to improve biological collections of patients presenting rare neurological disorders with known or suspected autoimmune origin. This collection will provide appropriate biol...
Detailed Description
Neuroimmunology is a rapidly expanding field since major advances have been made in basic immunology and numerous new clinical entities have been identified in the last 10 years. Even if these discove...
Eligibility Criteria
Inclusion
- all patients with neurological disorders, with known or probable autoimmune involvement. This includes adults and children and peripheral and/or central nervous system symptoms.
- Social coverage up to date.
Exclusion
- Patients with neurological damage from which the autoimmune character can be excluded.
- Known anemia and hemoglobin \<10 g / dl
- Patients under protective supervision (guardianship, curators)
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
October 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 3 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04698421
Start Date
October 12 2020
End Date
September 3 2030
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Purpan University Hospital
Toulouse, France, 31059